APIDC Venture Capital
2
6M
1
0.50
1
- Areas of investment
Summary
The venture was found in Asia in India. The main department of described VC is located in the Hyderabad.
We also calculated 1 valuable employee in our database.
The higher amount of exits for fund were in 2009. Deals in the range of 5 - 10 millions dollars are the general things for fund. The high activity for fund was in 2006. The fund is constantly included in less than 2 deals per year.
For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. Among the most popular portfolio startups of the fund, we may highlight Evolva. Besides, a startup needs to be aged 1 and less years to get the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Health Care.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the APIDC Venture Capital, startups are often financed by Yamanouchi Venture Capital, Novartis Venture Fund, Dansk Innovation. The meaningful sponsors for the fund in investment in the same round are Yamanouchi Venture Capital, Novartis Venture Fund, Dansk Innovation. In the next rounds fund is usually obtained by Novartis Venture Fund, Dansk Innovation, Aravis Ventures.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Exits
- 1
- Follow on index
- 0.50
- Investments by industry
- Wellness (2)
- Consulting (2)
- Health Care (2)
- Biotechnology (2)
- Food and Beverage (2)
- Investments by region
-
- Switzerland (2)
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Evolva | 01 Dec 2006 | Biotechnology, Food and Beverage, Health Care, Wellness, Consulting | Early Stage Venture | 10M | Switzerland, Aargau |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.